Aurora Cannabis August 2024 Investor Presentation

Aurora Cannabis presents its diversified global business model spanning international medical, Canadian medical, adult recreational, and plant propagation segments. The company highlights 24% year-over-year growth in international medical revenue, leadership positions in key markets, and science-driven innovation delivering 30% per-unit cost improvements. Aurora outlines its strategy for achieving positive free cash flow and creating shareholder value through M&A and operational excellence.